BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 699395)

  • 1. Home treatment of uremia with gastrointestinal dialysis.
    Tang CK; Huang TP; Lian JD; Chung HM
    Clin Nephrol; 1978 Jul; 10(1):21-6. PubMed ID: 699395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. II. Clinical results of long-term treatment.
    Norée LO; Bergström J
    Clin Nephrol; 1975; 3(5):195-203. PubMed ID: 1149344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremia with low serum creatinine-an entity produced by marked creatinine secretion.
    Bastl C; Katz MA; Shear L
    Am J Med Sci; 1977; 273(3):289-92. PubMed ID: 868918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting skeletal muscle membrane potential as an index of uremic toxicity. A proposed new method to assess adequacy of hemodialysis.
    Cotton JR; Woodard T; Carter NW; Knochel JP
    J Clin Invest; 1979 Mar; 63(3):501-6. PubMed ID: 429569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of oral gastrointestinal dialysis as therapy for psoriasis.
    Bamford JT; Myers TT
    Arch Dermatol; 1981 May; 117(5):276-7. PubMed ID: 7224655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Connecticut patients receiving services for end-stage uremia.
    Pearson DA; Stranova TJ; Thompson JD
    Public Health Rep; 1975; 90(5):440-8. PubMed ID: 809795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical results of long-term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia.
    Alvestrand A; Ahlberg M; Fürst P; Bergström J
    Clin Nephrol; 1983 Feb; 19(2):67-73. PubMed ID: 6839554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home hemodialysis: a comparison of in-center and home hemodialysis therapy in a cohort of successful home hemodialysis patients.
    Sands JJ; Lacson E; Ofsthun NJ; Kay JC; Diaz-Buxo JA
    ASAIO J; 2009; 55(4):361-8. PubMed ID: 19506463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variations in prolactinemia in 26 uremic subjects treated by periodic hemodialysis].
    Deambrogio P; Vanni M; Aleo AG
    Minerva Med; 1985 Apr; 76(17-18):847-9. PubMed ID: 4000528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urea and creatinine generation and removal in a pregnant patient receiving peritoneal dialysis.
    Lew SQ; Watson JA
    Adv Perit Dial; 1992; 8():131-5. PubMed ID: 1361769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-weekly hemodialysis helps continuous ambulatory peritoneal dialysis patients who have insufficient solute removal.
    Kanno Y; Suzuki H; Nakamoto H; Okada H; Sugahara S
    Adv Perit Dial; 2003; 19():143-7. PubMed ID: 14763051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in disequilibrium symptoms during dialysis with low glucose dialyzate.
    Raju SF; White AR; Barnes TT; Smith PP; Kirchner KA
    Clin Nephrol; 1982 Sep; 18(3):126-9. PubMed ID: 7140023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarrhea therapy of uremia.
    Young TK; Lee SC; Tang CK
    Clin Nephrol; 1979 Feb; 11(2):86-91. PubMed ID: 455815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.